We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to move medicines safely by air, following good distribution practice (GDP).
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
An overview of the five technologies selected for the AI Airlock pilot.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
AI Airlock programme develops industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
summary
General advice on vigilance - electronic cigarettes devices and refill containers.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
Advice for manufacturers, members of the public and professional users of software or apps being used during the COVID-19 pandemic.
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions.
MHRA scientific and regulatory advice for COVID-19 vaccine developers
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
VDEC provides a number of services for vaccines post-licensure
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Information for local authorities in England about the grant, which will support local authorities to deliver routine commissioning of PrEP in 2020 to 2021.
Submitting annual reports on sales of electronic cigarettes and refill containers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).